Literature DB >> 18637144

Recent status of drug-induced liver injury.

Hajime Takikawa1.   

Abstract

Drug-induced liver injury is an major cause of acute liver injury and the incidence of drug-induced liver injury seems to be increasing with an increase in the number of new drugs available. The diagnostic scale of drug-induced liver injury was been modified by the International Consensus Meeting during Digestive Disease Week, Japan 2004, which includes the score of the drug-lymphocyte stimulation test and eosinophilia. Although the modified diagnostic scale is useful, and widely used in Japan, there will be many issues to be investigated in the future. According to a recent survey of drug-induced liver injury cases in Japan, drug-induced liver injury from dietary supplements are increasing, as has been observed in foreign countries. More research is needed to elucidate the mechanisms of drug metabolism and the pathophysiology of liver injury by various drugs to prevent drug-induced liver injury.

Entities:  

Year:  2008        PMID: 18637144     DOI: 10.1111/j.1872-034X.2008.00400.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  7 in total

1.  Graft-versus-host disease: unexpected presentation with simultaneous hepatitis and pancreatitis.

Authors:  Samuel Raimundo Fernandes; Antonio T Alves; Margarida Barreto Cortes; Helena Cortez-Pinto
Journal:  BMJ Case Rep       Date:  2016-08-02

2.  In-depth identification of pathways related to cisplatin-induced hepatotoxicity through an integrative method based on an informatics-assisted label-free protein quantitation and microarray gene expression approach.

Authors:  Young-Eun Cho; Thoudam S K Singh; Hyun-Chul Lee; Pyong-Gon Moon; Jeong-Eun Lee; Myung-Hoon Lee; Eung-Chil Choi; Yu-Ju Chen; Sang-Hyun Kim; Moon-Chang Baek
Journal:  Mol Cell Proteomics       Date:  2011-10-24       Impact factor: 5.911

3.  Drug-induced liver injury after allogeneic bone marrow transplantation.

Authors:  Takayoshi Tachibana; Akito Nozaki; Makiko Enaka; Eri Yamamoto; Rika Kawasaki; Hideyuki Koharazawa; Maki Hagihara; Daisuke Ishibashi; Yuki Nakajima; Hideyuki Kuwabara; Naoto Tomita; Yoshiaki Ishigatsubo; Shin Fujisawa
Journal:  Int J Hematol       Date:  2013-09-15       Impact factor: 2.490

4.  A case of cholestatic hepatitis associated with histologic features of acute cholangitis.

Authors:  Hajime Takeuchi; Toru Kaneko; Toshikazu Otsuka; Kumiko Tahara; Tadashi Motoori; Makoto Ohbu; Masaya Oda; Hiroaki Yokomori
Journal:  Int J Gen Med       Date:  2011-11-23

5.  An Autopsy Case of Fulminant Hepatitis in a Patient with Multiple Sclerosis Treated by Interferon-Beta-1a.

Authors:  Yuichi Yamazaki; Aya Suzuki; Kimitoshi Hirayanagi; Yusuke Tsukagoshi; Ryota Uehara; Kazuhiko Horiguchi; Tatsuya Ohyama; Takuya Tomaru; Norio Horiguchi; Sumihito Nobusawa; Hayato Ikota; Ken Sato; Satoru Kakizaki; Motoyasu Kusano; Yoshio Ikeda; Hideaki Yokoo; Masanobu Yamada
Journal:  Intern Med       Date:  2017-07-15       Impact factor: 1.271

6.  Drug-induced Liver Injury Associated with Mosapride Citrate: A Report of Two Cases.

Authors:  Ayaka Sako; Sung Kwan Bae; Toshifumi Gushima; Junichi Motoshita; Shigemune Bekki; Seigo Abiru; Atsumasa Komori; Shinji Shimoda; Masahiro Ito; Hiroshi Yatsuhashi; Kazuhiro Takahashi
Journal:  Intern Med       Date:  2017-01-01       Impact factor: 1.271

7.  Development of Autoimmune Hepatitis during Direct-acting Antiviral Therapy for Chronic Hepatitis C Virus Infection.

Authors:  Kotaro Matsumoto; Kentaro Kikuchi; Yusuke Kajiyama; Yuichi Takano; Masatoshi Mabuchi; Shinpei Doi; Koichiro Sato; Hiroshi Miyakawa; Ichiro Yasuda
Journal:  Intern Med       Date:  2018-04-27       Impact factor: 1.271

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.